Collegium Announces Underwriters’ Exercise of Option to Purchase Additional Shares
Nov 29, 2016 12:30 pm UTC| Business
CANTON, Mass., Nov. 29, 2016 -- Collegium Pharmaceutical, Inc. (Nasdaq:COLL) announced that the underwriters for its public offering of 5,000,000 shares of its common stock at $16.00 per share have exercised in full...
Nov 29, 2016 12:30 pm UTC| Business
PARSIPPANY, N.J., Nov. 29, 2016 -- Pacira Pharmaceuticals, Inc. (NASDAQ:PCRX) today announced a joint endeavor with GeneAlign, a therapeutic management and solutions company working to revolutionize personalized...
Delta Apparel Reports Fiscal 2016 Fourth Quarter and Year-End Results
Nov 29, 2016 12:30 pm UTC| Business
GREENVILLE, S.C., Nov. 29, 2016 -- Delta Apparel, Inc. (NYSE MKT:DLA) today reported that all of its businesses, with the exception of Junkfood, experienced sales growth during the fourth quarter ended October 1, 2016....
KalVista Pharmaceuticals Appoints Edward P. Feener, Ph.D. as Chief Scientific Officer
Nov 29, 2016 12:30 pm UTC| Business
CAMBRIDGE, Mass. and PORTON DOWN, United Kingdom, Nov. 29, 2016 -- KalVista Pharmaceuticals, Inc. (NASDAQ:KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of...
Akorn Launches Ibuprofen Oral Suspension
Nov 29, 2016 12:30 pm UTC| Business
LAKE FOREST, Ill., Nov. 29, 2016 -- Akorn, Inc. (Nasdaq:AKRX), a leading specialty pharmaceutical company, today announced that it has launched the prescription version of Ibuprofen 100mg/5mL oral suspension in 118mL...
Nov 29, 2016 12:30 pm UTC| Business
KP201/IR could be the first single entity (APAP-free), IR hydrocodone product for pain analgesia with abuse-deterrent properties CORALVILLE, Iowa, Nov. 29, 2016 -- KemPharm, Inc. (NASDAQ:KMPH), a clinical-stage...
KaloBios to Present at JMML International Symposium
Nov 29, 2016 12:30 pm UTC| Business
BRISBANE, Calif., Nov. 29, 2016 -- KaloBios Pharmaceuticals, Inc. (OTC:KBIO), a biopharmaceutical company focused on advancing medicines for patients with neglected and rare diseases, announced that Dr. Tariq Arshad,...